The Journal of Immunology · 1982 · 81 citations · 0 references
Life SciencesImmunologyCellular ImmunologyClinical ImmunologyImmunopathologyCytokine BiologyCytokine RegulationImmune Cell PhysiologyImmune FunctionImmune RegulationImmune ResponseCytokine SynthesisImmune Cell ActivationTh2 Immune Response
Abstract In PBM obtained from 24 immunodeficient patients (two severe combined immunodeficiencies, three cases of Wiskott-Aldrich syndrome, two immunodeficiencies with hyper IgM, three cases of X-linked agammaglobulinemia, and 14 common variable immunodeficiencies) and from 19 age-matched controls, we have studied 1) the proliferative response to optimal and suboptimal doses of PHA after “in vitro” supplementation of the cultures with mitogen-free supernatants containing II 2 (IL 2 Sup), and 2) the production of IL 2 in response to an optimal dose of PHA. Addition of IL 2 Sup to cultures of normal PBM stimulated with 1% or 0.05% PHA did not cause significant augmentation of proliferative response, and only at a very low PHA dose (0.02%) did the addition of IL 2 Sup induce an increment of the DNA synthesis. On the other hand, addition of IL 2 Sup to lymphocytes from immunodeficient patients stimulated with the suboptimal dose of PHA (0.05%) caused an enhancement of the DNA synthesis, which in most cases never reached the levels observed in normal individuals, and was more manifest in those patients who showed a PHA response below the normal level. The production of IL 2 was significantly lower (p < 0.01) in the immunodeficient patients with a reduced proliferative response to PHA, and was in the normal range (p < 0.03) in immunodeficient patients with a normal or borderline PHA response. When all the data from controls and patients were pooled for regression analysis, a significant correlation was found between DNA synthesis and IL 2 production (r = + 0.64, p < 0.01 ), between DNA synthesis and its enhancement after IL 2 Sup addition (r = − 0.48, p < 0.01 ), and between IL 2 production and the enhancement of DNA synthesis after IL 2 Sup addition (r = − 0.48, p < 0.01). The main conclusion is that the hyporesponse to PHA, in our group of immunodeficient patients, is associated with, but not exclusively due to, a defect in the production of IL 2.